Everolimus
Everolimus is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay. Everolimus induces cell apoptosis and autophagy and inhibits tumor cells proliferation.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S1120 |
| Sku # | S1120-1g |
| Pricing | 1g, $970.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2020Quote: ... everolimus (Selleck Chemicals # S1120), navitoclax (Selleck Chemicals # S1001) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Vehicle (20% DMSO in PBS) or 0.01 mg/kg RAD001 (Selleck Chemical, #S1120) was administered daily in 100 μL ...
-
bioRxiv - Cancer Biology 2023Quote: ... Everolimus (S1120) and Bortezomib (S1013) were purchased from Selleck Chemicals. Human Methylcellulose enriched media (HSC005 ...